Cytel are a $300m global leader in statistical analytics for clinical drug discovery and development. Their 360° services include SaaS platforms, consultancy and clinical trial design. They are owned by Nordic Capital and at the height of a global acquisition trail.
AUK has helped to build the Cytel marketing strategy and team from the ground up by introducing a content first approach to inbound marketing for lead generation. This is an account based marketing programme designed to cultivate case studies and thought leadership among their prospect databases and communities.
Our activity has unified the Cytel brand with an architecture flexible enough to accommodate brand names from future acquisitions.